Journal article

No evidence for PALB2 methylation in high-grade serous ovarian cancer

Thomas Mikeska, Kathryn Alsop, Gillian Mitchell, David DL Bowtell, Alexander Dobrovic

JOURNAL OF OVARIAN RESEARCH | BIOMED CENTRAL LTD | Published : 2013

Grants

Awarded by National Breast Cancer Foundation Collaborative Breast Cancer Research Grant Program


Awarded by U.S. Army Medical Research and Materiel Command


Awarded by National Health and Medical Research Council of Australia (NHMRC)


Awarded by Ovarian Cancer Research Program of the US Department of Defense


Awarded by National Breast Cancer Foundation


Funding Acknowledgements

AD received funding from the National Breast Cancer Foundation Collaborative Breast Cancer Research Grant Program (CG-08-07) and the Cancer Council of Victoria. The Australian Ovarian Cancer Study was supported by the U.S. Army Medical Research and Materiel Command under DAMD17-01-1-0729, The Cancer Council Tasmania, The Cancer Foundation of Western Australia, the National Health and Medical Research Council of Australia (NHMRC; ID400413), and was approved by the Human Research Ethics Committees at the Peter MacCallum Cancer Centre, Queensland Institute of Medical Research, University of Melbourne and all participating hospitals. The Genotyping in the Australian Ovarian Cancer Study project was supported by the Ovarian Cancer Research Program of the US Department of Defense (W81XWH-08-1-0684 and W81XWH-08-1-0685) (DDLB and GM), Cancer Australia (DDLB and GM) and the National Breast Cancer Foundation (ID509303) (GM), the Peter MacCallum Cancer Centre Foundation (GM) and the Cancer Council Victoria (postgraduate scholarship for KA). We gratefully acknowledge the cooperation of the participating institutions in Australia, and also acknowledge the contribution of the study nurses, research assistants and all clinical and scientific collaborators. The complete AOCS Study Group can be found at www.aocstudy.org. We would like to thank all of the women who participated in the study.